Cambridge Healthtech Institute’s 11th Annual
Cell Therapy Manufacturing
August 20-21, 2025
Led by new technology and a move towards new indications such as autoimmune disease, the cell therapy industry is back. Cambridge Healthtech Institute's Cell Therapy Manufacturing conference examines the practical challenges facing the manufacture of autologous and allogenic cell therapies at scale, with dedicated sessions on automation and closed systems, process design and development, cell processing, next-generation production technologies, scalability, artificial intelligence, supply chain, and facility design. The meeting will include examples from autologous and allogeneic therapies in the fields of CAR Ts, IPSCs, NK cells, TILs, and gamma deltas.
Coverage will include, but is not limited to:
- CAR T for Autoimmune Disease
- Point-of-Care Manufacturing
- Manufacturing and Automation
- Process Development for Emerging Cell Therapies
- In vivo Engineering of Immune Cells
- Using Data, AI, and Digitalization in Cell Therapy Manufacturing
The deadline for priority consideration is January 27, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: